Articles with keyword chemotherapy

• Metronomic chemotherapy: efficacy in real clinical practice

  V.A. Chubenko, L.A. Zagorskaya, V.S. Chubenko, F.V. Moiseenko, N.Kh. Abduloeva, A.S. Zhabina, M.M. Kramchaninov, K.V. Shelekhova, A.A. Meldo, E.M. Zykov, A.A. Kudryavcev, E.V. Napolskaya, V.M. Moiseyenko

  metronomic chemotherapy, stable disease, time to progression, toxicity.

• Cancer resistance to chemotherapy – are all possibilities exhausted?

  N.М. Volkov

  malignant tumors, chemotherapy, cytostatics, resistance.

• Intraperitoneal chemotherapy in patients with advanced ovarian cancer: phase 2 institutional study

  A.S. Tyulyandina, V.М. Nechushkina, L.V. Cherkes, K.Y. Morkhov, A.A. Rumyantsev, I.A. Pokataev, E.V. Glazkova, E.R. Virshke, D.Y. Frantsev, K.I. Zhordania, Y.V. Bujdenok, R.K. Valiev, A.V. Petrovsky, Y.S. Sergeev, I.V. Panichenko, A.A. Bulanov, M.B. Stenina, S.A. Tyulyandin

  ovarian cancer, intraperitoneal chemotherapy, intravenous chemotherapy, optimal cytoreduction, cisplatin, paclitaxel.

• OLANZAPINE VERSUS APREPITANT IN PATIENTS RECEIVING HIGH-EMETOGENIC CHEMOTHERAPY: INTERIM ANALYSIS OF RANDOMIZED PHASE II TRIAL

  A.A. Rumyantsev, E.V. Glazkova, R.Yu. Nasyrova, E.O. Ignatova, L.V. Chitia, A.S. Popova, Kh.Kh. Elsnukaeva, I.A. Pokataev, A.S. Tyulyandina, M.B. Stenina, M.A. Frolova, A.A. Bulanov, V.Yu. Fedyanin, O.V. Sekhina, A.A. Tryakin, S.A. Tjulandin

  olanzapine, aprepitant, chemotherapy, supportive care, CINV, nausea, vomiting.

• First line dosointensive chemotherapy for Disseminated ovarian cancer after non optimal Cyted reduction: Results of the phase ii study

  A.A. Rumyantsev, A.S. Tyulyandina, I.A. Pokataev, K.Yu. Morkhov, V.M. Nechushkina, V.E. Nikulin, S.O. Nikogosyan, K.I. Zhordania, S.A. Tyulyandin

  ovarian cancer, dose-dense chemotherapy, dose-intensive chemotherapy, suboptimal debulking, non-optimal debulking.

• Long-lasting full remission after selective intra-arterial chemotherapy for recurrence of locally advanced oral mucosa carcinoma

  I.P. Moshurov, A.N. Redkin, N.A. Znatkova, M.S. Olshansky, A.Yu. Shklyarov, A.V. Tsurikova, S.A. Stikina

  squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation, intra-arterial chemotherapy, chemoembolization.

• FIFTEEN COURSES OF SELECTIVE INTRA-ARTERIAL CHEMOTHERAPY FOR RELAPSE OF CANCER OF THE ORAL MUCOSA IN ONE PATIENT

  M.S. Olshansky, A.Yu. Shklyarov, Yu.S. Konstantinova, E.N. Suhochev, S.A. Stikina, A.N. Redkin

  squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation treatment, intraarterial chemotherapy.

• Immunotherapy Resistance – Finding Solutions

  M.Yu. Fedyanin

  cancer, chemotherapy, immunotherapy, resistance.

• Analysis of the work of the central chemotherapy drugs breeding department in the State Medical Institution «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological) named after N.P. Napalkov» 2014–2022

  V.M. Moiseenko, A.S. Zhabina, F.V. Moiseenko, N.M. Volkov, V.V. Yegorenkov, R.A. Ranzhina, N.K. Abduloeva

  Drugs, chemotherapy, cytostatics breeding, safety of staff, quality, control, workload reduction, saving.

• Efficacy of neoadjuvant endocrine therapy in HR-positive/HER2-negative breast cancer: A review

  N.K. Abduloeva, V.M. Moiseenko, F.V. Moiseenko, O.A. Skripko, M.V. Scriabin, R.A. Ryandjina

  Neoadjuvant endocrine therapy, neoadjuvant chemotherapy.

• What has changed in clinical oncology practice In 2019?

  M.Y. Fedyanin

  cancer, chemotherapy, immunotherapy, targeted therapy.

• NEW APPROACHES TO ADJUVANT THERAPY OF MALIGNANT TUMORS

  K.S. Titov, A.V. Krasnorutsky, A.M. Kazakov, D.A. Ryabchikov

  adjuvant chemotherapy, breast cancer, colorectal cancer, melanoma, sarcoma.

• Pending issues of standard approaches in oncology

  A.A. Tryakin, M.Yu. Fedyanin, I.A. Pokataev, A.V. Petrovsky

  clinical guidelines, standards of care, chemotherapy, oncology.

• Combinations of immunotherapy and other drugs

  V.A. Chubenko

  Target therapy, chemotherapy, check-point inhibitors, overall survival.

• MEDICAL ERRORS IN THE DIAGNOSIS AND TREATMENT OF MALIGNANT TROPHOBLASTIC TUMORS

  Z.A. Gasanbekova, L.A. Meshcheryakova, S.A. Aliev, V.V. Kuznetsov

  trophoblastic, tumors, choriocarcinoma, bladder skeleton, chorionic gonadotropin, chemotherapy.

• BIOPSY OF THE LYMPH NODES IN BREAST CANCER

  E.M. Bit-Sava, M.G. Anchabandze, M.A. Monogarova, V.M. Moiseyenko

  biopsy of signaling lymph nodes, axillary lymphadenectomy, neoadjuvant chemotherapy.

• MEDICAL TREATMENT OF TUMORS: WHAT NEED TO KNOW A PRAC TICAL ONCOLOGIST

  V.A. Chubenko

  chemotherapy, immunotherapy, target therapy, overall survival, treatment guidelines.

• Anemia and thrombocytopenia induced by antitumor therapy

  I.A. Koroleva

  сancer-and chemotherapy-induced anaemia (CIA), intravenous iron, ferric carboxymaltose, erythropoesis-stimulating agents (ESAs), сhemotherapy induced thrombocytopenia (CIT).

• Debulking surgery in oncogynecology

  S.Ya. Maximov, I.V. Sobolev, A.S. Hadjimba, A.A. Ilin, E.D. Gershfeld, D.-K. Reyes Santiago

  cytoreductive, debulking surgery, ovarian cancer, cervical cancer, endometrial cancer, chemotherapy, radiotherapy

• Clinical management of peritoneal metastases from colorectal cancer

  D. Baratti, Sh. Kusamura, M. Guaglio, M. Deraco

  colorectal cancer, peritoneal metastasis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, liver metastasis

• PROMISING METHODS FOR THE TREATMENT OF METASTATIC BREAST CANCER

  A.S. Zhabina

  metastatic breast cancer, high-dose chemotherapy, metronome therapy, vaccine therapy, adoptive therapy.

• RE-IRRADIATION THERAPY FOR RECURRENT BRAIN TUMORS

  O.I. Shcherbenko, O.S. Regentova

  brain tumors, relapses, radiation therapy, chemotherapy, medulloblastoma, ependymoma, glioma, brain stem tumor, radiation injuries.

• Practical and theoretical issues of surgery in oncology

  V.V. Egorenkov

  surgical oncology, minimally invasive surgery, sentinel node biopsy, cytoreductive surgery, intraoperative chemotherapy, reconstructive surgery.

• The most important results of clinical trials for breast cancer systemic therapy in 2021

  S.A. Tjulandin, М.В. Stenina, М.А. Frolova

  breast cancer, immunotherapy, endocrine therapy, chemotherapy, gene expression assay, BRCA1/2-associated breast cancer.

• CHANGES IN NEO- AND ADJUVANT TREATMENT OF BREAST CANCER IN THE LAST 5 YEARS

  M.B. Stenina, M.A. Frolova, D.Z. Kupchan, S.A. Tjulandin

  early breast cancer, neo-adjuvant therapy, adjuvant therapy, radiotherapy, chemotherapy, hormonotherapy, anti-HER2 therapy, ovarian suppression.

• Surgical decision making in treating patients with metastatic tumors. focus on surgical treatment of peritoneal carcinomatosis

  O.E. Kalinin, V.V. Gushchin

  peritoneal carcinomatosis, cytoreductive surgery, curative surgery, palliative surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, stage IV cancer, metastatic disease

• Clinical experience of afatinib application In non-cell lung cancer of lung. Ii line of therapy

  L.M. Kogoniya, E.V. Markarova, G.A. Stashuk, V.E. Shikina

  lung cancer, adenocarcinoma, non-small cell lung cancer, EGFR mutation, chemotherapy, targeted therapy, efficacy, elderly, side effects

• Urgent issues of drug therapy and possible solutions

  E.V. Karabina

  precision oncology, effectiveness of immunotherapy of malignant tumors, effectiveness of chemotherapy of malignant tumors, recovery of patients with advanced cancer.